The Case of an Acute Promyelocytic Leukemia (APL) Patient with Severe Renal Dysfunction Who Obtained Remission by Induction of Hemodialysis and APL Treatment-Reference-Cited by-同舟云学术

The Case of an Acute Promyelocytic Leukemia (APL) Patient with Severe Renal Dysfunction Who Obtained Remission by Induction of Hemodialysis and APL Treatment

Published:2022-03-10 Issue:3 Volume:48 Page:136-142
ISSN:1346-342X
Container-title:Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
language:en
Short-container-title:Jpn. J. Pharm. Health Care Sci.

Author:

Hayashida Soshi¹,Mori Yoshihiro¹,Sadoh Shinichi¹,Iwamura Naoya¹,Ichinose Masamitsu²,Tsusima Hideki²,Higuchi Norihide¹

Affiliation:

1. Department of Pharmacy, Nagasaki Harbor Medical Center

2. Hematology, Nagasaki Harbor Medical Center

Publisher

Japanese Society of Pharmaceutical Health Care and Sciences

Subject

General Earth and Planetary Sciences,General Environmental Science

Link

https://www.jstage.jst.go.jp/article/jjphcs/48/3/48_136/_pdf

Reference13 articles.

1. 1）一般社団法人日本血液学会, “造血器腫瘍診療ガイドライン2018年版”, 補訂版, 金原出版, 東京, 2020.

2. 2）東條有伸, ATRAによる急性前骨髄球性白血病の分化誘導療法, 内科臨床誌メディチーナ, 1993, 30, 658-660.

3. 3）Tsuchiya Y, Ubara Y, Suwabe T, Hoshino J, Sumida K, Hiramatsu R, Hasegawa E, Yamanouchi E, Hayami N, Marui Y, Sawa N, Takemoto F, Takaichi K, Successful treatment of acute promyelocytic leukemia in a patient on hemodialysis, Clin Exp Nephrol, 2011, 15, 434-437.

4. 4）瀧谷公隆, 玉井　浩, 急性前骨髄性白血病におけるレチノイン酸薬物動態の検討, 日本ビタミン学会, 2011, 85, 631-644.

5. 5）水地大輔, 飯山光子, 血液維持透析中に発症した急性前骨髄球性白血病患者におけるATRAとAs₂O₃による治療経験, 臨床血液, 2012, 53, 1321.